SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: StockDung6/29/2009 6:53:09 PM
   of 5582
 
Federman & Sherwood Announces Investigation of Matrixx Initiatives, Inc. for Possible Securities Laws Violations
Mon. June 29, 2009; Posted: 06:03 PM


OKLAHOMA CITY, Jun 29, 2009 (GlobeNewswire via COMTEX) -- MTXX | Quote | Chart | News | PowerRating -- Federman & Sherwood, an Oklahoma-based law firm specializing in securities and consumer litigation, has launched an investigation into possible securities fraud by Matrixx Initiatives, Inc. (Nasdaq:MTXX). Although the company has recalled its Zicam nasal products, the company has been investigated by the SEC with respect to its marketing practices, and it is believed that information surrounding the Zicam line of products, as well as the Company's liability in connection with these products, was not reaching the Company's shareholders.
If you are a shareholder or former employee of Matrixx Initiatives and you have information that would assist our firm in its ongoing investigation, or if you have other questions relating to a loss you may have suffered in your investment, please contact William B. Federman at wbf@federmanlaw.com or (405) 235-1560.

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: Federman & Sherwood

Federman & Sherwood
(405) 235-1560
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext